Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 15

    1.

    Telomere length predicts all-cause mortality in patients with type 1 diabetes.

    Astrup AS, Tarnow L, Jorsal A, Lajer M, Nzietchueng R, Benetos A, Rossing P, Parving HH.

    Diabetologia. 2009 Oct 4. [Epub ahead of print]PMID: 19802713 [PubMed - as supplied by publisher]Related articles

    2.

    Effect of adjunct metformin treatment on levels of plasma lipids in patients with type 1 diabetes.

    Lund SS, Tarnow L, Astrup AS, Hovind P, Jacobsen PK, Alibegovic AC, Parving I, Pietraszek L, Frandsen M, Rossing P, Parving HH, Vaag AA.

    Diabetes Obes Metab. 2009 Oct;11(10):966-77. Epub 2009 Jun 25.PMID: 19558610 [PubMed - in process]Related articles

    3.

    Tubular and glomerular injury in diabetes and the impact of ACE inhibition.

    Nielsen SE, Sugaya T, Tarnow L, Lajer M, Schjoedt KJ, Astrup AS, Baba T, Parving HH, Rossing P.

    Diabetes Care. 2009 Sep;32(9):1684-8. Epub 2009 Jun 5.PMID: 19502542 [PubMed - indexed for MEDLINE]Related articles

    4.

    Optimal dose of lisinopril for renoprotection in type 1 diabetic patients with diabetic nephropathy: a randomised crossover trial.

    Schjoedt KJ, Astrup AS, Persson F, Frandsen E, Boomsma F, Rossing K, Tarnow L, Rossing P, Parving HH.

    Diabetologia. 2009 Jan;52(1):46-9. Epub 2008 Oct 31.PMID: 18974967 [PubMed - indexed for MEDLINE]Related articles

    5.

    Effect of adjunct metformin treatment in patients with type-1 diabetes and persistent inadequate glycaemic control. A randomized study.

    Lund SS, Tarnow L, Astrup AS, Hovind P, Jacobsen PK, Alibegovic AC, Parving I, Pietraszek L, Frandsen M, Rossing P, Parving HH, Vaag AA.

    PLoS One. 2008;3(10):e3363. Epub 2008 Oct 9.PMID: 18852875 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Markers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years: association with mortality and decline of glomerular filtration rate.

    Astrup AS, Tarnow L, Pietraszek L, Schalkwijk CG, Stehouwer CD, Parving HH, Rossing P.

    Diabetes Care. 2008 Jun;31(6):1170-6. Epub 2008 Mar 10.PMID: 18332153 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Relation of left ventricular function, mass, and volume to NT-proBNP in type 1 diabetic patients.

    Astrup AS, Kim WY, Tarnow L, Botnar RM, Simonsen C, Brix L, Pietraszek L, Hansen PR, Manning WJ, Parving HH.

    Diabetes Care. 2008 May;31(5):968-70. Epub 2008 Feb 5.PMID: 18252905 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Plasma alpha-defensin is associated with cardiovascular morbidity and mortality in type 1 diabetic patients.

    Joseph G, Tarnow L, Astrup AS, Hansen TK, Parving HH, Flyvbjerg A, Frystyk J.

    J Clin Endocrinol Metab. 2008 Apr;93(4):1470-5. Epub 2008 Jan 22.PMID: 18211979 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Predictors of mortality in patients with type 2 diabetes with or without diabetic nephropathy: a follow-up study.

    Astrup AS, Nielsen FS, Rossing P, Ali S, Kastrup J, Smidt UM, Parving HH.

    J Hypertens. 2007 Dec;25(12):2479-85.PMID: 17984670 [PubMed - indexed for MEDLINE]Related articles

    10.

    Pregnancy-associated plasma protein A in a large cohort of Type 1 diabetic patients with and without diabetic nephropathy-a prospective follow--up study.

    Astrup AS, Tarnow L, Christiansen M, Hansen PR, Parving HH, Rossing P.

    Diabet Med. 2007 Dec;24(12):1381-5. Epub 2007 Oct 29.PMID: 17971180 [PubMed - indexed for MEDLINE]Related articles

    11.

    Subclinical coronary and aortic atherosclerosis detected by magnetic resonance imaging in type 1 diabetes with and without diabetic nephropathy.

    Kim WY, Astrup AS, Stuber M, Tarnow L, Falk E, Botnar RM, Simonsen C, Pietraszek L, Hansen PR, Manning WJ, Andersen NT, Parving HH.

    Circulation. 2007 Jan 16;115(2):228-35. Epub 2006 Dec 26.PMID: 17190865 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Cardiac autonomic neuropathy predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.

    Astrup AS, Tarnow L, Rossing P, Hansen BV, Hilsted J, Parving HH.

    Diabetes Care. 2006 Feb;29(2):334-9.PMID: 16443883 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Elevated placental growth factor (PlGF) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.

    Tarnow L, Astrup AS, Parving HH.

    Scand J Clin Lab Invest Suppl. 2005;240:73-9.PMID: 16112962 [PubMed - indexed for MEDLINE]Related articles

    14.

    Improved prognosis in type 1 diabetic patients with nephropathy: a prospective follow-up study.

    Astrup AS, Tarnow L, Rossing P, Pietraszek L, Riis Hansen P, Parving HH.

    Kidney Int. 2005 Sep;68(3):1250-7.PMID: 16105058 [PubMed - indexed for MEDLINE]Related articles

    15.

    Monitoring kidney function in diabetic nephropathy.

    Rossing P, Astrup AS, Smidt UM, Parving HH.

    Diabetologia. 1994 Jul;37(7):708-12.PMID: 7958543 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...